Stati Uniti

Slitta la decisione americana sull'uso del vaccino Moderna sugli adolescenti

SDA

1.11.2021 - 06:57

epa09149751 A Romanian doctor displays a vial of the Covid-19 Moderna vaccine, at the mobile vaccination center installed in the yard of the public school of Afumati village, near Bucharest, Romania, 21 April 2020. Starting from 21 April, the Romanian Army launched 20 new mobile vaccination centers against COVID-19 throughout the country, in order to speed-up the vaccination campaign in isolated or hard to reach localities. Mobile vaccination centers are serviced by military medical personnel, and assisted by civilian paramedics. Romanian authorities hope to reach 100,000 vaccinations a day. EPA/ROBERT GHEMENT
epa09149751 A Romanian doctor displays a vial of the Covid-19 Moderna vaccine, at the mobile vaccination center installed in the yard of the public school of Afumati village, near Bucharest, Romania, 21 April 2020. Starting from 21 April, the Romanian Army launched 20 new mobile vaccination centers against COVID-19 throughout the country, in order to speed-up the vaccination campaign in isolated or hard to reach localities. Mobile vaccination centers are serviced by military medical personnel, and assisted by civilian paramedics. Romanian authorities hope to reach 100,000 vaccinations a day. EPA/ROBERT GHEMENT
KEYSTONE

La casa farmaceutica Moderna ha reso noto che le autorità regolatorie americane hanno ritardato la decisione sull'approvazione del vaccino anti Covid per gli adolescenti per avere più tempo per valutare il potenziale rischio di miocarditi e pericarditi.

SDA

1.11.2021 - 06:57

«La Food and Drug Administration ha informato «Moderna che l'agenzia richiede ulteriore tempo per valutare le recenti analisi internazionali sul rischio di miocarditi dopo la vaccinazione», ha spiegato la società.

La valutazione se raccomandare o meno il vaccino ai ragazzi tra i 12 e i 17 anni potrebbe durare sino al prossimo gennaio, ha precisato l'azienda.

SDA